Pierre Brousset is an expert in Hematology at Hôtel-Dieu Saint-Jacques (France). As of September 2026, ScienceLeadR ranks Pierre Brousset in the top 1% of experts worldwide for Lymphoma. Pierre Brousset has authored 384 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,126 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Pierre Brousset Hôtel-Dieu Saint-Jacques France
1 126 ScienceLeadR Reputation 1126
Network Map

Hematology

Subspecialties: Oncology - Neurosurgery - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1989 - 2026

Source: PubMed

Hôtel-Dieu Saint-Jacques

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 384

Citations

Citations: 14 042 1st author: 43 Last author: 89 Unique author: 10


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
A High Density of Impaired Tertiary Lymphoid Structures Is Associated with Higher Tumor Stage and Recurrence in Non-Muscle-Invasive Bladder Cancer.
PMID 42671925 — urinary bladder, urinary bladder neoplasms, cells, muscles, cystitis, neoplasms, tertiary lymphoid structures, non-muscle invasive bladder neoplasms
Cancer Immunol Res20260
TOP2 and NOS2 Orchestrate the Generation of DNA Breaks to Promote Colitis Cancer Initiation.
PMID 42192880 — colitis, nitric oxide synthase, neoplasms, colon, inflammatory bowel diseases, dna breaks, dna
Cancers (Basel)20260
Patient-Derived Lymphoma Spheroids Reveal Predictive Markers of Glofitamab Resistance in Relapsed/Refractory B-NHL.
PMID 41746860 — cells, hematology, lymphoma, therapeutics
Blood20260
Biological feature-based machine learning in histopathological images: a systematic review.
PMID 41623734 — cells, pathologists, pathology, machine learning, learning, tissues
J Pathol Inform20260
Expectations and Limitations of Artificial Intelligence in Blood Cancer Diagnosis.
PMID 41586511 — intelligence, blood, neoplasms, diagnosis, artificial intelligence
Blood Cancer Discov20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 1

By status:

Recruiting 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map